KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer
Keitaro Shimozaki, Eiji Shinozaki, Noriko Yamamoto, Yu Imamura, Hiroki Osumi, Izuma Nakayama, Takeru Wakatsuki, Akira Ooki, Daisuke Takahari, Mariko Ogura, Keisho Chin, Masayuki Watanabe, Kensei Yamaguchi
Topics & Concepts
TrastuzumabKRASMedicineInternal medicineNeuroblastoma RAS viral oncogene homologOncologyHazard ratioCancerColorectal cancerCetuximabBreast cancerConfidence intervalHER2/EGFR in Cancer ResearchGastric Cancer Management and OutcomesColorectal Cancer Treatments and Studies